Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation -- Ignore unavailable to you. Want to Upgrade?

To: Mark Bong who wrote (1433)	8/10/2000 1:50:17 PM
From: aknahow	Read Replies (2) \| Respond to of 52153

As long as the SEC continues to grant confidential status to almost anything a company wants to classify as confidential, in required SEC filings, a significant amount of important information will be kept from shareholders but not from management, and corporate employees nor SEC staff. Without updates and hints to analyst this store of information will become even more valuable. When the price of a commodity goes up more will be willing to sell the information to others or use it themselves. While there are legitimate reasons for not disclosing the terms of agreements the SEC could at least impose a reporting burden by requiring a detailed explanation of how and why disclosure would damage the competitive position of the company.